Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 4, 2009, Pages 741-746

  Smee, Donald F ^a   Hurst, Brett L ^a   Egawa, Hiroyuki ^b   Takahashi, Kazumi ^b   Kadota, Takumi ^b   Furuta, Yousuke ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Antiviral; Guanosine triphosphate; Phosphorylation; Ribavirin; RNA polymerase

Indexed keywords

ANTIVIRUS AGENT; FAVIPIRAVIR; GUANOSINE TRIPHOSPHATE; RIBAVIRIN; T 705; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL METABOLISM; CELL STRAIN; CONTROLLED STUDY; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLUENZA VIRUS A H5N1; NONHUMAN; ULTRAVIOLET SPECTROSCOPY; VIRUS TITRATION;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; DOGS; GUANOSINE TRIPHOSPHATE; INFLUENZA A VIRUS, H5N1 SUBTYPE; PYRAZINES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70349443188     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp274     Document Type: Article

References (13)

1. Furuta Y, Takahashi K, Shiraki K et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res 2009; 82: 95-102.
2. Furuta Y, Takahashi K, Kuno-Maekawa M et al. Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother 2005; 49: 981-6.
3. Streeter DG, Witkowski JT, Khare GP et al. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad spectrum antiviral agent. Proc Natl Acad Sci USA 1973; 70 1174-8.
4. Smee DF, Matthews TR. Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells. Antimicrob Agents Chemother 1986; 30: 117-21.
5. Smee DF, Bray M, Huggins JW. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir Chem Chemother 2001; 12: 327-35.
6. Eriksson B, Helgstrand E, Johannson NG et al. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother 1977; 11: 946-51.
7. Lowe JK, Brox L, Henderson JF. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and Virazole. Cancer Res 1977; 37: 736-43.
8. Müller WEG, Maidhof A, Taschner H et al. Virazole (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), a cytostatic agent. Biochem Pharmacol 1977; 26: 1071-5.
9. Smee DF, Bray M, Huggins JW. Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent. Antivir Chem Chemother 2001; 12: 251-8.
10. Smee DF, Humphreys DE, Hurst BL et al. Antiviral activities and phosphorylation of 5-halo-2′-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus. Antivir Chem Chemother 2008; 19: 15-24.
11. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-7.
12. Furuta Y, Takahashi K, Fukuda Y et al. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother 2002; 46: 977-81.
13. Sidwell RW, Barnard DL, Day CW et al. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother 2007; 51: 845-51.